On August 27, 2009, Baeyens-Cabrera, Jose Manuel; Buschmann, Helmut H.; Vela-Hernandez, Jose-Miguel; Zamanillo-Castanedo, Daniel; Nieto-Lopez, Francisco Rafael published a patent.Product Details of 4569-86-2 The title of the patent was Use of compounds binding to the sigma receptor for the treatment of neuropathic pain developing as a consequence of chemotherapy. And the patent contained the following:
The present invention refers to the use of compounds binding to the sigma receptor for the treatment or prevention of neuropathic pain resulting from chemotherapy. The invention discloses the use of compounds binding to the sigma receptor for the treatment or prevention of neuropathic pain resulting from chemotherapy. The experimental process involved the reaction of 3-Amino-7-(diethylamino)-5-phenylphenazin-5-ium chloride(cas: 4569-86-2).Product Details of 4569-86-2
The Article related to chemotherapy neuropathic pain treatment sigma receptor ligand analgesic, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Product Details of 4569-86-2
Referemce:
Chloride – Wikipedia,
Chlorides – an overview | ScienceDirect Topics